MT
Michael Thomas Henderson
DELAYED 1 MONTH
Director; Director, Chief Executive Officer
Apogee Therapeutics, Inc.
Spyre Therapeutics, Inc.
Filings
4
Companies
2
Latest
May 27, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
68
APGECLUSTER 3
Apogee Therapeutics, Inc.
Michael Thomas Henderson
Director, Chief Executive Officer
Sale
$1.6M
20,000 sh
May 16 12:00 AM
May 13, 2026
76
Spyre Therapeutics, Inc.
Michael Thomas Henderson
Director
Sale
$6.0M
80,000 sh
May 9 1:31 AM
May 8, 2026
68
APGECLUSTER 3
Apogee Therapeutics, Inc.
Michael Thomas Henderson
Director, Chief Executive Officer
Sale
$1.5M
20,000 sh
Mar 14 12:00 AM
Mar 11, 2026